Larry Biegelsen
Stock Analyst at Wells Fargo
(4.64)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
COO Cooper Companies | Maintains: Overweight | 93 72 | 68.25 | 5.49% | 18 | Aug 28, 2025 | |
MDT Medtronic | Maintains: Overweight | 98 100 | 94.08 | 6.29% | 18 | Aug 20, 2025 | |
HYPR Hyperfine | Maintains: Equal-Weight | 1 1 | 1.27 | -33.07% | 6 | Aug 15, 2025 | |
TNDM Tandem Diabetes Care | Maintains: Equal-Weight | 20 13 | 12.56 | 3.5% | 10 | Aug 7, 2025 | |
EW Edwards Lifesciences | Maintains: Overweight | 84 88 | 79.83 | 10.23% | 17 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Equal-Weight | 93 | 78.88 | 17.9% | 9 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 174 101 | 81.44 | 24.02% | 13 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 435 445 | 392.8 | 13.29% | 15 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 137 131 | 130.34 | 0.51% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 6 3 | 1.69 | 77.51% | 7 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 33 24 | 24.48 | -1.96% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 86 92 | 90.83 | 1.29% | 15 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 12 15 | 15.3 | -1.96% | 7 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 108 100 | 91.66 | 9.1% | 11 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 315 290 | 286.95 | 1.06% | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 40 15 | 12.66 | 14.53% | 18 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 118 124 | 108.1 | 14.71% | 13 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 559 599 | 467.54 | 28.12% | 20 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 28 27 | 17.87 | 51.09% | 2 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 25 9 | 9.78 | -7.98% | 14 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 113 98 | 103.86 | -5.64% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 103 89 | 78.71 | 13.07% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 13 17 | 9.97 | 70.51% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 166 152 | 176.97 | -14.11% | 13 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 65 80 | 79.97 | 0.04% | 6 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 90 94 | 78.4 | 19.9% | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 17 14 | 5.84 | 139.73% | 11 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 200 210 | 334.75 | -37.27% | 6 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 68 71 | n/a | n/a | 6 | Jan 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 40 49 | 15.43 | 217.56% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 140 136 | 131.95 | 3.07% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 80 70 | 59.08 | 18.48% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 58 62 | 39.75 | 55.97% | 6 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 279 270 | 190.52 | 41.72% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 2 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Apr 25, 2017 |